$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
Prev. Close
About ADC Therapeutics SA
ADC Therapeutics SA is a clinical-stage biotechnology company, which develops antibody drug conjugates. Its products include ADCT-402 and ADCT-301. The company was founded on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Sector
Health Technology
CEO
Industry
Pharmaceuticals: Major
Exchange
New York Stock Exchange
Website
Top Stories
Coming soon.